Matthew S. Petrie

431 total citations
15 papers, 332 citations indexed

About

Matthew S. Petrie is a scholar working on Toxicology, Cellular and Molecular Neuroscience and Epidemiology. According to data from OpenAlex, Matthew S. Petrie has authored 15 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Toxicology, 3 papers in Cellular and Molecular Neuroscience and 3 papers in Epidemiology. Recurrent topics in Matthew S. Petrie's work include Forensic Toxicology and Drug Analysis (4 papers), Poisoning and overdose treatments (2 papers) and Psychedelics and Drug Studies (2 papers). Matthew S. Petrie is often cited by papers focused on Forensic Toxicology and Drug Analysis (4 papers), Poisoning and overdose treatments (2 papers) and Psychedelics and Drug Studies (2 papers). Matthew S. Petrie collaborates with scholars based in United States and Canada. Matthew S. Petrie's co-authors include Alan H.B. Wu, Kara L. Lynch, Deborah French, Patil Armenian, Roy Gerona, Douglas E. Vaughan, Layton H. Smith, Sean Ekins, Matthew D. Krasowski and Mesut Eren and has published in prestigious journals such as Circulation Research, The Journal of Clinical Endocrinology & Metabolism and Journal of Lipid Research.

In The Last Decade

Matthew S. Petrie

15 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew S. Petrie United States 9 104 93 68 42 36 15 332
Catherine Féliu France 11 36 0.3× 65 0.7× 31 0.5× 22 0.5× 22 0.6× 36 329
Wei‐Jian Pan United States 14 72 0.7× 83 0.9× 11 0.2× 56 1.3× 37 1.0× 34 501
Pedro Martı́nez Spain 10 48 0.5× 82 0.9× 34 0.5× 52 1.2× 34 0.9× 20 468
Marc Luginbühl Switzerland 14 99 1.0× 115 1.2× 30 0.4× 49 1.2× 120 3.3× 30 381
Chadi Abbara France 12 94 0.9× 102 1.1× 10 0.1× 13 0.3× 11 0.3× 58 464
Nele Sadones Belgium 7 102 1.0× 74 0.8× 24 0.4× 28 0.7× 229 6.4× 8 394
Anna Gruca Poland 13 13 0.1× 124 1.3× 15 0.2× 73 1.7× 40 1.1× 38 402
Nick Verougstraete Belgium 11 57 0.5× 74 0.8× 21 0.3× 15 0.4× 105 2.9× 22 289
Apichaya Puangpetch Thailand 16 37 0.4× 111 1.2× 13 0.2× 26 0.6× 51 1.4× 37 596
Jennifer A. Sandberg United States 16 40 0.4× 255 2.7× 17 0.3× 6 0.1× 25 0.7× 27 677

Countries citing papers authored by Matthew S. Petrie

Since Specialization
Citations

This map shows the geographic impact of Matthew S. Petrie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew S. Petrie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew S. Petrie more than expected).

Fields of papers citing papers by Matthew S. Petrie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew S. Petrie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew S. Petrie. The network helps show where Matthew S. Petrie may publish in the future.

Co-authorship network of co-authors of Matthew S. Petrie

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew S. Petrie. A scholar is included among the top collaborators of Matthew S. Petrie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew S. Petrie. Matthew S. Petrie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
3.
Smollin, Craig G., Matthew S. Petrie, & Thomas E. Kearney. (2016). Carbamazepine and carbamazepine-10,11-epoxide clearance measurements during continuous venovenous hemofiltration in a massive overdose. Clinical Toxicology. 54(5). 424–427. 4 indexed citations
4.
Crews, Bridgit & Matthew S. Petrie. (2015). Recent Trends in Designer Drug Abuse. Clinical Chemistry. 61(7). 1000–1001. 3 indexed citations
5.
Greene, Dina N., et al.. (2014). Challenges in harmonizing integrated healthcare network laboratories: Multi-center evaluation of the AccuTnI+3 troponin assay. Clinical Biochemistry. 48(4-5). 268–274. 9 indexed citations
6.
Greene, Dina N., et al.. (2014). Performance characteristics of the Beckman Coulter total βhCG (5th IS) assay. Clinica Chimica Acta. 439. 61–67. 11 indexed citations
7.
8.
Stone, Judith, Dina N. Greene, Matthew S. Petrie, et al.. (2013). Falsely Undetectable TSH in a Cohort of South Asian Euthyroid Patients. The Journal of Clinical Endocrinology & Metabolism. 99(4). 1171–1179. 17 indexed citations
9.
Wu, Alan H.B., Roy Gerona, Patil Armenian, et al.. (2012). Role of liquid chromatography–high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology. Clinical Toxicology. 50(8). 733–742. 139 indexed citations
10.
Petrie, Matthew S., et al.. (2012). Prescription Compliance or Illicit Designer Drug Abuse?. Clinical Chemistry. 58(12). 1631–1634. 7 indexed citations
11.
Petrie, Matthew S., Stephen D. Hess, & Anthony V. Benedetto. (2011). Automated 15-Minute Cytokeratin 7 Immunostaining Protocol for Extramammary Paget's Disease in Mohs Micrographic Surgery. Dermatologic Surgery. 37(12). 1811–1815. 9 indexed citations
12.
Petrie, Matthew S., et al.. (2010). Keratoacanthoma of the Head and Neck with Perineural Invasion: Incidental Finding or Cause for Concern?. Dermatologic Surgery. 36(7). 1209–1213. 7 indexed citations
13.
Taylor, Sarah L., Matthew S. Petrie, Kenneth S. O’Rourke, & Steven R. Feldman. (2009). Rheumatologists’ recommendations on what to do in the dermatology office to evaluate and manage psoriasis patients’ joint symptoms. Journal of Dermatological Treatment. 20(6). 350–353. 20 indexed citations
14.
Smith, Layton H., Matthew S. Petrie, Jason D. Morrow, John A. Oates, & Douglas E. Vaughan. (2005). The sterol response element binding protein regulates cyclooxygenase-2 gene expression in endothelial cells. Journal of Lipid Research. 46(5). 862–871. 16 indexed citations
15.
Smith, Layton H., Stephen R. Coats, Hao Qin, et al.. (2004). Differential and Opposing Regulation of PAI-1 Promoter Activity by Estrogen Receptor α and Estrogen Receptor β in Endothelial Cells. Circulation Research. 95(3). 269–275. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catherine Féliu Breakdown of academic impact, for papers by Wei‐Jian Pan Breakdown of academic impact, for papers by Pedro Martı́nez Breakdown of academic impact, for papers by Marc Luginbühl Breakdown of academic impact, for papers by Chadi Abbara Breakdown of academic impact, for papers by Nele Sadones Breakdown of academic impact, for papers by Anna Gruca Breakdown of academic impact, for papers by Nick Verougstraete Breakdown of academic impact, for papers by Apichaya Puangpetch Breakdown of academic impact, for papers by Jennifer A. Sandberg
Rankless by CCL
2026